Continuous Heparin Infusion to Prevent Catheter-related Thrombosis

Status Completed

Clinical Trial Summary

Clinical Trial Description

Catheter-related thrombosis could impair blood flow in the vein, block the central venous catheter, induce catheter-related infection or venous thromboembolism in the deep veins or pulmonary vessels, which furthermore progress into the post-thrombotic syndrome. Researches using echogenic mass as the primary outcome could miss those premature thrombi which might not be seen on traditional ultrasonography but may be detected by Duplex and Doppler ultrasound with vessel compression. Moreover, studies indicated that some thrombus developed after the catheter removal. Removal of the catheter is not the endpoint of thrombus detection. This study is designed to determine the preventive effects of continuous heparin infusion on real-world central venous catheter-related thrombosis in infants after cardiac surgery. One hundred and twenty-four infants were randomized to the intervention group or the control group. Unfractionated heparin or normal saline was infused continuously through each lumen of the central venous catheter at the speed of 0.5 ml/h/line until the catheter was removed. Catheter-related thrombosis was detected by point-of-care Duplex and Doppler ultrasound periodically until 30 days after the cardiac surgery or discharge, whichever comes first. ;

Study Design

Related Conditions & MeSH terms

Cardiac Surgery
Central Venous Catheter Thrombosis
Heparin
Thrombosis
Upper Extremity Deep Vein Thrombosis

Clinical Trial Details

NCT number	NCT04767113
Study type	Interventional
Source	Guangdong Provincial People's Hospital
Contact
Status	Completed
Phase	N/A
Start date	March 1, 2021
Completion date	August 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05054179` - Pecto-Intercostal Fascial Plane Block Catheter Trial for Reduction of Sternal Pain	Phase 2/Phase 3
Completed	`NCT04051021` - Non-Pharmacological Interventions on Patient Experience and Healthcare Utilization in Adult Cardiac Surgery Patients	N/A
Recruiting	`NCT04604886` - The Consistency of Cardiac Output Measured by Pulmonary Artery Catheter and LiDCO in Cardiac Surgical Patients	N/A
Recruiting	`NCT04075981` - Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)	Phase 3
Completed	`NCT04062396` - Comparison of Remowell 2 and Inspire on Delirium and Cognitive Dysfunction	N/A
Recruiting	`NCT04709705` - DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS)	Phase 2/Phase 3
Not yet recruiting	`NCT05563662` - SURgical Registry of ENDocarditis EuRope
Withdrawn	`NCT03289104` - Improving Sternal Healing After Cardiac Surgery: Sternal Wire vs ZIPFIX	N/A
Completed	`NCT04199039` - Effects of Endotracheal Tube Fixation Methods on Hemodynamic Parameters During Endotracheal Suction	N/A
Completed	`NCT02964026` - Study of Clinical Outcomes Associated With the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients	N/A
Completed	`NCT03563196` - Diagnosis Of Pulmonary Complications After Cardiac Surgery In Children
Completed	`NCT02471001` - The Levels of Anaesthetics in Heart Muscle During Heart Surgery	N/A
Completed	`NCT02325726` - RRI Compared With NephroCheckTM to Predict Acute Renal Failure After Cardiac Surgery.	N/A
Completed	`NCT01246947` - Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Miral Operation	N/A
Completed	`NCT01151254` - Comparison of Propofol Based Versus Volatile Based Anesthesia and Postoperative Sedation	N/A
Completed	`NCT00996099` - Continuous Glucose Monitoring Combined With Computer Algorithm for Intensive Insulin Therapy in Cardiosurgical Patients	N/A
Completed	`NCT00821262` - Sevoflurane in Cardiac Surgery	Phase 4
Completed	`NCT00617955` - Effects of Aprotinin During Cardiac Surgery/Long Term Death Rates	N/A
Completed	`NCT00337805` - Double Blind Randomized Trial of Saline vs Pentaspan for Resuscitation After Cardiac Surgery	Phase 2/Phase 3
Completed	`NCT00336466` - The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.